Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis.

Fernandes BS, Berk M, Turck CW, Steiner J, Gonçalves CA.

Mol Psychiatry. 2014 Jul;19(7):750-1. doi: 10.1038/mp.2013.172. Epub 2013 Dec 17. No abstract available.

PMID:
24342989
2.

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders?

Gass P, Hellweg R.

Int J Neuropsychopharmacol. 2010 Feb;13(1):1-4. doi: 10.1017/S1461145709991039. Epub 2009 Dec 9. No abstract available.

PMID:
19995480
3.

Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.

Hashimoto K.

Psychiatry Clin Neurosci. 2010 Aug;64(4):341-57. doi: 10.1111/j.1440-1819.2010.02113.x. Review. Erratum in: Psychiatry Clin Neurosci. 2010 Oct;64(5):590.

4.

Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.

Fernandes BS, Steiner J, Berk M, Molendijk ML, Gonzalez-Pinto A, Turck CW, Nardin P, Gonçalves CA.

Mol Psychiatry. 2015 Sep;20(9):1108-19. doi: 10.1038/mp.2014.117. Epub 2014 Sep 30.

PMID:
25266124
5.

BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis.

Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA.

World J Biol Psychiatry. 2014 Jul;15(5):411-8. doi: 10.3109/15622975.2014.892633. Epub 2014 Mar 16. Review.

PMID:
24628093
6.

Correlation between brain damage, associated biomarkers, and medication in psychiatric inpatients: A cross-sectional study.

Yoshida M, Kanzaki T, Mizoi M, Nakamura M, Uemura T, Mimori S, Uju Y, Sekine K, Ishii Y, Yoshimi T, Yasui R, Yasukawa A, Sato M, Okamoto S, Hisaoka T, Miura M, Kusanishi S, Murakami K, Nakano C, Mizuta Y, Mishima S, Hayakawa T, Tsukada K, Kashiwagi K, Igarashi K.

Clin Chim Acta. 2017 Jan;464:50-56. doi: 10.1016/j.cca.2016.11.002. Epub 2016 Nov 3.

PMID:
27816667
7.

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.

Yamamori H, Hashimoto R, Ishima T, Kishi F, Yasuda Y, Ohi K, Fujimoto M, Umeda-Yano S, Ito A, Hashimoto K, Takeda M.

Neurosci Lett. 2013 Nov 27;556:37-41. doi: 10.1016/j.neulet.2013.09.059. Epub 2013 Oct 18.

8.

Serum BDNF levels before and after the development of mood disorders: a case-control study in a population cohort.

Ihara K, Yoshida H, Jones PB, Hashizume M, Suzuki Y, Ishijima H, Kim HK, Suzuki T, Hachisu M.

Transl Psychiatry. 2016 Apr 12;6:e782. doi: 10.1038/tp.2016.47.

9.

Ethnic differences in the serum levels of proBDNF, a precursor of brain-derived neurotrophic factor (BDNF), in mood disorders.

Hashimoto K.

Eur Arch Psychiatry Clin Neurosci. 2016 Apr;266(3):285-7. doi: 10.1007/s00406-015-0641-x. Epub 2015 Sep 4. No abstract available.

PMID:
26338800
10.

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.

Teixeira AL, Barbosa IG, Diniz BS, Kummer A.

Biomark Med. 2010 Dec;4(6):871-87. doi: 10.2217/bmm.10.111.

PMID:
21133708
11.
12.

Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders.

da Graça Cantarelli M, Nardin P, Buffon A, Eidt MC, Antônio Godoy L, Fernandes BS, Gonçalves CA.

J Affect Disord. 2015 Feb 1;172:403-9. doi: 10.1016/j.jad.2014.10.033. Epub 2014 Oct 22.

13.

[BDNF measurement in stress-related mood disorders: a review of clinical studies].

Aydemir O, Deveci A.

Turk Psikiyatri Derg. 2009 Winter;20(4):385-91. Review. Turkish.

14.

Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.

Reis HJ, Nicolato R, Barbosa IG, Teixeira do Prado PH, Romano-Silva MA, Teixeira AL.

Neurosci Lett. 2008 Jul 11;439(2):157-9. doi: 10.1016/j.neulet.2008.05.022. Epub 2008 May 13.

PMID:
18514407
15.

Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.

Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ.

Mol Psychiatry. 2011 Sep;16(9):960-72. doi: 10.1038/mp.2010.88. Epub 2010 Aug 24. Review.

PMID:
20733577
16.

Brain Derived Neurotrophic Factor (BDNF) levels as a possible predictor of psychopathology in healthy twins at high and low risk for affective disorder.

Vinberg M, Miskowiak K, Kessing LV.

Psychoneuroendocrinology. 2014 Jan;39:179-83. doi: 10.1016/j.psyneuen.2013.09.007. Epub 2013 Sep 17.

PMID:
24112874
17.

Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls.

Shimizu E, Hashimoto K, Watanabe H, Komatsu N, Okamura N, Koike K, Shinoda N, Nakazato M, Kumakiri C, Okada S, Iyo M.

Neurosci Lett. 2003 Nov 13;351(2):111-4.

PMID:
14583394
18.

The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.

Vinberg M, Miskowiak K, Hoejman P, Pedersen M, Kessing LV.

PLoS One. 2015 May 26;10(5):e0127629. doi: 10.1371/journal.pone.0127629. eCollection 2015.

19.

Circulating anti-brain autoantibodies in schizophrenia and mood disorders.

Margari F, Petruzzelli MG, Mianulli R, Campa MG, Pastore A, Tampoia M.

Psychiatry Res. 2015 Dec 15;230(2):704-8. doi: 10.1016/j.psychres.2015.10.029. Epub 2015 Oct 30.

PMID:
26548982
20.

Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.

Yang YQ, Sun S, Yu YQ, Li WJ, Zhang X, Xiu MH, Chen DC, De Yang F, Liu H, Li C, Kosten TR, Zhang XY.

Neurosci Lett. 2011 Sep 8;502(1):37-40. doi: 10.1016/j.neulet.2011.07.020. Epub 2011 Jul 20.

PMID:
21798311

Supplemental Content

Support Center